Compare JQC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JQC | IART |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.9M | 877.1M |
| IPO Year | N/A | 1995 |
| Metric | JQC | IART |
|---|---|---|
| Price | $5.06 | $11.30 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 714.6K | 713.9K |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 11.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,642,966,000.00 |
| Revenue This Year | N/A | $3.26 |
| Revenue Next Year | N/A | $2.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.99 |
| 52 Week Low | $4.82 | $10.60 |
| 52 Week High | $5.65 | $25.45 |
| Indicator | JQC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 44.47 |
| Support Level | $5.02 | $10.60 |
| Resistance Level | $5.14 | $11.33 |
| Average True Range (ATR) | 0.04 | 0.54 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 10.00 | 54.81 |
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.